October 5, 2009
For immediate release
OTTAWA - The Honourable Leona Aglukkaq, Minister of Health, today announced the appointment of Dr. Bernard Prigent to the Governing Council of the Canadian Institutes of Health Research (CIHR) for a three-year term.
"Dr. Prigent brings extensive pharmaceutical research industry experience to CIHR's Governing Council," said Minister Aglukkaq. "His understanding of research and development partnerships will be a valuable asset."
Dr. Bernard Prigent is Vice President and Medical Director of Pfizer Canada. He has worked on the clinical development and commercialization of new medicines in a variety of therapeutic areas, including cardiology, respiratory medicine, infectious disease, rheumatology, urology, neurology and oncology.
He holds an MD from the Faculté de médecine Xavier-Bichat, Paris VII de l'Université de Paris and an MBA from Henley Business School at the University of Reading in the UK.
Biographies for the members of the CIHR Governing Council can be found on the CIHR website.
The Canadian Institutes of Health Research (CIHR) is the Government of Canada's agency for health research. CIHR's mission is to create new scientific knowledge and to enable its translation into improved health, more effective health services and products, and a strengthened Canadian health-care system. Composed of 13 Institutes, CIHR provides leadership and support to more than 13,000 health researchers and trainees across Canada.
Office of the Honourable Leona Aglukkaq
Federal Minister of Health
CIHR Media Relations